Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk factors for the development of lithium-induced polyuria.

K L L Movig1, R Baumgarten, H G M Leufkens

  • 1Hospital Pharmacy Midden-Brabant, Tilburg, The Netherlands.

The British Journal of Psychiatry : the Journal of Mental Science
|April 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Definitions, measurement, and reporting of progression-free survival in randomized clinical trials and observational studies of patients with advanced non-small-cell lung cancer treated with immunotherapy: a scoping review.

ESMO real world data and digital oncology·2026
Same author

Uncertainties about the benefit-risk balance of oncology medicines assessed by the European Medicines Agency.

ESMO open·2024
Same author

Busulfan Exposure Target Attainment in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation: A Single Day Versus a Multiple Day Therapeutic Drug Monitoring Regimen.

Transplantation and cellular therapy·2024
Same author

Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation.

BMC health services research·2024
Same author

Pharmaceutical Scientists' Perspectives on Capacity Building in Pharmaceutical Sciences.

Journal of pharmaceutical sciences·2023
Same author

Cost-utility analysis of a structured medication review compared to usual care in Parkinson's disease.

European journal of clinical pharmacology·2022

Polyuria, or excessive urination, affects 37% of patients on lithium for bipolar disorder. Combining lithium with serotonergic antidepressants significantly increases this risk.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Nephrology

Background:

  • Polyuria is a frequent side effect in patients with bipolar disorder undergoing lithium treatment.
  • Risk factors contributing to polyuria in this patient population remain largely uncharacterized.

Purpose of the Study:

  • To determine the prevalence of polyuria in patients using lithium.
  • To identify additional risk factors associated with lithium-induced polyuria.

Main Methods:

  • A prospective, 4-month follow-up study was conducted at an outpatient lithium clinic.
  • Seventy-five participants provided 24-hour urine samples, with polyuria defined as >3 liters/24h.
  • Evaluated risk factors included demographics, concurrent medications, and comorbidities.

Related Experiment Videos

Main Results:

  • The prevalence of polyuria among lithium users was found to be 37%.
  • Concomitant use of serotonergic antidepressants showed a significant association with polyuria (OR 4.25, 95% CI 1.15-15.68).

Conclusions:

  • The study confirms a high prevalence of lithium-induced polyuria.
  • Concurrent use of serotonergic antidepressants with lithium substantially elevates the risk.
  • While not always harmful, polyuria can be bothersome, and lithium cessation may not be feasible for symptom control.